Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023

Clinical trial NCT01348516 · COMPLETED

Trial details

NCT number: NCT01348516
Sponsor: Kainos Medicine Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus

Start date: 2011-05-01
Primary completion: 2012-03-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.